Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	92.04	111	134.34	129.32	157.53	92.57
Cash & Short-Term Investments	92.04	111	134.34	129.32	157.53	92.57
Cash Growth	-33.87%	-17.38%	3.89%	-17.91%	70.17%	417.27%
Accounts Receivable	-	-	0.4	4.1	-	-
Other Receivables	-	-	0.95	2.83	-	-
Receivables	-	-	1.35	6.93	-	-
Prepaid Expenses	2.42	2.07	2.47	3.96	3.44	0.34
Restricted Cash	-	-	0.21	-	0.1	-
Total Current Assets	94.46	113.07	138.37	140.2	161.07	92.91
Property, Plant & Equipment	11.71	12.32	14.85	17.45	16.33	3.12
Long-Term Deferred Charges	-	-	-	-	-	0.16
Other Long-Term Assets	1.07	1.54	21.62	2.59	1.86	0.21
Total Assets	107.24	126.93	174.83	160.25	179.25	96.4
Accounts Payable	0.99	3.04	1.34	1.22	2.04	1.02
Accrued Expenses	9.02	10.23	8.41	13.41	8.6	3.49
Current Portion of Long-Term Debt	-	-	6.67	-	-	-
Current Portion of Leases	1.41	1.56	1.61	2.08	1.07	0.68
Current Unearned Revenue	-	-	0.91	6.53	-	-
Other Current Liabilities	0.25	0.36	0.45	0.74	0.16	0.09
Total Current Liabilities	11.67	15.18	19.38	23.99	11.87	5.28
Long-Term Debt	26.59	26.1	32.66	-	-	-
Long-Term Leases	9.02	9.44	10.99	12.6	14.59	1.86
Long-Term Unearned Revenue	-	-	0.43	1.13	-	-
Other Long-Term Liabilities	2.66	2.83	-	0.19	-	0.03
Total Liabilities	49.93	53.54	63.46	37.91	26.46	7.18
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	489.98	487.97	455.44	429.04	405.68	-
Retained Earnings	-432.68	-414.59	-344.07	-306.71	-252.9	-51.87
Total Common Equity	57.31	73.39	111.37	122.34	152.79	-51.86
Shareholders' Equity	57.31	73.39	111.37	122.34	152.79	89.22
Total Liabilities & Equity	107.24	126.93	174.83	160.25	179.25	96.4
Total Debt	37.01	37.09	51.92	14.68	15.66	2.54
Net Cash (Debt)	55.03	73.91	82.42	114.63	141.87	90.03
Net Cash Growth	-37.41%	-10.33%	-28.10%	-19.20%	57.58%	509.99%
Net Cash Per Share	1.25	1.69	2.31	3.97	7.69	89.58
Filing Date Shares Outstanding	44.87	44.83	42.74	35.28	27.65	1.75
Total Common Shares Outstanding	44.83	44.83	39.11	31.52	27.61	1.75
Working Capital	82.79	97.89	118.99	116.21	149.19	87.63
Book Value Per Share	1.28	1.64	2.85	3.88	5.53	-29.70
Tangible Book Value	57.31	73.39	111.37	122.34	152.79	-51.86
Tangible Book Value Per Share	1.28	1.64	2.85	3.88	5.53	-29.70
Machinery	-	3.34	3.16	2.32	1.07	0.64
Construction In Progress	-	-	-	0.11	1.96	-
Leasehold Improvements	-	7.97	7.97	7.97	0.27	0.19

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q